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Introduction 
Chlamydias are obligate intracellular parasites of vertebrates, of some arthropod species, and of 
several free-living amoebae (1,2,3). They exhibit a peculiar two-stage developmental cycle that 
includes an extra- cellular infectious elementary body and an intracellular vegetative reticulate 
body. A further infective stage, the crescent body, was recently described for the 
Parachlamydiaceae (4), a new family within the order Chlamydiales. 
The family Chlamydiaceae comprises two genera, Chlamydia and Chlamydophila (5). While 
Chlamydia species seem to infect only mammals such as humans, rodents, and swine, host 
specificity for Chlamydophila species is less strict, including for amphibians, reptiles, birds, and 
mammals (6). Both Chlamydia and Chlamydophila species comprise important human pathogens . 
Chlamydia trachomatis is a common cause of urogenital infection in humans and the agent of 
trachoma, one of the leading infectious causes of blindness worldwide. Chlamydophila pneumoniae 
is another important human pathogen, causing mainly respiratory infections. C. pneumoniae might 
also be involved in the pathogenesis of atherosclerotic cardiovascular diseases and 
neurodegenerative syndromes (7). The other species are mainly veterinary pathogens, though some 
of them may cause rare but severe anthropozoonotic infections, such as psittacosis due to 
Chlamydophila psittaci or zoonotic abortion due to Chlamoydophila abortus (8,9,10). 
Historically, the term “chlamydia-like organisms” has been applied to refer to any intracellular 
microorganism that, like Chlamydiaceae, exhibited a two-stage developmental cycle. Since 
phylogenetic molecular analyses performed on some of these chlamydia-like organisms have 
showed this group to be polyphyletic, the term “chlamydia-like organisms” is only descriptive and 
retains no taxonomic value. Other authors (11) proposed the term “environmental chlamydiae” to 
refer to chlamydial organisms that fall outside the family Chlamydiaceae, with the latter being 
designated “pathogenic chlamydiae.” However, such a distinction seems inadequate, since a 
growing body of evidence supports the pathogenic role of some of these chlamydiae (12,13). By 
analogy to the term “amoeba-resistant microorganisms” (14), the term “amoeba-resisting 
chlamydias” could also be applied to the species that may infect and survive within amoebae, i.e., 
Parachlamydiaceae, Simkania negevensis, and Waddlia chondrophila (15,16,17). Indeed, most of 
these new species exhibited symbiotic or lytic interaction with amoebae. Nevertheless, since not all 
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new species of chlamydiae have been tested for their ability to resist destruction by free-living 
amoebae, the more general term “novel chlamydiae” should be preferred to designate all the 
chlamydiae not belonging to the Chlamydiaceae. These chlamydiae, which have recently been 
discovered and assigned to new families, are currently being investigated for their role as emerging 
pathogens.  
Simkania negevensis (family Simkaniaceae)  and Parachlamydia acanthamoebae (family 
Parachlamydiaceae) could represent important respiratory pathogens in humans, while Waddlia 
chondrophila (family Waddliaceae) seems to be a new agent of abortion in ruminants. 
Molecular studies performed on human and animal samples have demonstrated the wide 
biodiversity and broad host range of chlamydiae. Thus, additional Parachlamydiaceae species, such 
as Neochlamydia sp., and a large variety of new 16S rRNA gene phylotypes have been detected in 
humans, cats, Australian marsupials, reptiles, and fishes , as well as in various environmental 
samples. 
Moreover, new members of the Chlamydiales infecting invertebrates have recently been 
characterized. These include Fritschea bemisiae and Fritschea eriococci (family Simkaniaceae), 
which infect homopteran insects, and Rhabdochlamydia porcellionis (14) and Rhabdochlamydia 
crassificans, which infect the woodlouse Porcellio scaber (Crustacea: Isopoda) and the cockroach 
Blatta orientalis (Insecta: Blattodea), respectively. The presence of chlamydiae in arthropods is 
interesting, since arthropods were not previously considered to play a role in the epidemiology of 
chlamydial infections, with the only exception being flies as a vector of the agent of trachoma. To 
date, if we exclude cases of possible Rhabdochlamydia- related uveitis in humans, there is no hint 
that these invertebrate-associated chlamydiae may be pathogenic to humans. 
Evidence for a much larger biodiversity within Chlamydiales was afforded by several molecular 
studies performed on humans, animals, and environmental samples. 
Simkania negevensis is an intracellular bacterium that was first detected when rapidly moving 
particles were observed in cytoplasmic inclusions in laboratory stocks of Vero cells. Trasnsmission 
electron microscopy of thin section s revealed small, dense forms and larger, homogenous forms, 
similar in appearance to chlamydial elementary  and reticulate bodies.  
For years in the order of Chlamydiales was this one family , that of Chlamydiaceae containing only 
one genus , Chlamydia , and nine species : Chlamydia trachomatis , Chlamydia pneumoniae , 
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Chlamydia psittaci , Chlamydia pecorum , Chlamydia suis , felis Chlamydia , Chlamydia abortus , 
Chlamydia muridarum and Chlamydia caviae . The species C. trachomatis , C. pneumoniae and C. 
psittaci are responsible for human infections . C. trachomatis cause eye infections and urogenital , 
C. pneumoniae causes respiratory infections , while C. psittaci causes psittacosis - ornithosis (19) . 
Recently( 1999) , the introduction of data of the phylogenetic analysis of the 16S and 23S ribosomal 
RNA in studies of taxonomy , brought significant alterations in the order Chlamydiales with the 
recognition of four separate groups of chlamydiae , framed in terms of " family " . 
In the new classification, the family gathers Chlamydiaceae chlamydiae already known . Three other 
families , created to frame the new bacteria taxonomically " Chlamydia -like" recently discovered , are 
represented by the family Parachlamydiaceae with two species Parachlamydia acanthamoebae and 
Neochlamydia hartmannellae , family Waddliaceae with the only species Waddlia chondrophila and 
family Simkaniaceae with ' only species Simkania negevensis . These new families have more than 
80% homology to the sequences of the 16S rRNA genes of Chlamydia (21). 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Bacterial cell 
The bacteria belonging to the order Chlamydiales are particular microorganisms, similar to viruses 
for their parasitism obliged, and bacteria for mode of replication, antibiotic susceptibility, and the 
presence in them of DNA, RNA and ribosomes similar to those of the bacteria. Since metabolic 
point of view are able to synthesize autonomously various organic substances of low molecular 
weight. 
The main metabolic defect, because of their intracellular parasitism obliged, is represented by the 
absence of any enzyme system for the production of energy (ATP), therefore, are forced to source of 
ATP and other cofactors (NAD, CoA, etc.) from host cell.  
The bacterial structure is comparable to that of the Gram-negative bacteria, with a second 
membrane that, in the outer portion, has the characteristic component lipopolysaccharide (LPS or 
endotoxin) and by protein OMPs (Outer Membrane Proteins). The main protein is indicated by the 
acronym MOMP (Major Outer Membrane Protein), which has a structural function and metabolic 
as it acts as porin, allowing the entry of nutrients and essential molecules. Quite unique is the 
absence of peptidoglicanica component of the cell wall, replaced by a layer protein rich in cysteine 
(two proteins of 60 kDa and 15 kDa, respectively called large and small CRP or cystein-rich 
protein) that appears to be a functional equivalent of peptidoglycan, giving rigidity to the outer 
membrane through disulfide inter- and intra -molecular between proteins themselves. 
To the particular structure of outer casings seems to be related the ability of these microorganisms 
to prevent fusing with lysosomes, the phagosome in which they are introduced inside the cell 
parasitized. The absence of a wall formed by peptidoglycan explains their low or no sensitivity to 
beta-lactam antibiotics (and in any case to drugs that work by preventing the synthesis of 
peptidoglycan). 
The polypeptide pattern of S. negevensis obtained by SDS PAGE, is quite different from that of 
other members of the Chlamydiales. Only certain proteins, mainly heat shock, are shared by S. 
negevensis, W. chondrophila, P. acanthamoebae, C. pneumoniae and C. trachomatis. 
The analysis by immunoblot of cell lysates of S. negevensis by murine hyperimmune serum shows 
the predominant membrane antigens, which are a set of three bands of molecular weight between 
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37-42 kDa, and additional bands of 26, 52 , 58, and 64 kDa, and a band of PM greater than 100 
kDa. 
Monoclonal antibodies (MAbs) prepared against whole organisms or against cell lysates, react 
primarily with the set of bands between 37 and 42 kDa, indicating strong immunogenicity of the 
complex. Some of these MAbs were able to neutralize in vitro S. negevensis, but unable to 
neutralize C. trachomatis in the same conditions. When these MAbs specific for S. negevensis were 
tested by immunoblot of cell lysates prepared or membrane of C. trachomatis, they were able to 
recognize an epitope localized on the protein OmpA. On the other hand, the MAbs that recognize 
epitopes family-specific OmcB (OMP-2), OmpA (MOMP), and does not bind LPS antigens of S. 
negevensis. The structure and function of the three polypeptides belonging to the complex outer 
membrane of S. negevensis needs further study. It is possible that the shared epitope constitute part 
of a porin common to Chlamydiaceae and S. negevensis (21,22).    
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Taxonomic relationships 
S negevensis belongs to a new family, Simkaniaceae, in the order Chlamydiales based on its 
obligately intracellular parasitic growth in cultured cells, a biphasic morphology of electron dense 
and reticulated forms, size comparable to that of all known Chlamydiae, and rDNA sequence 
comparisons(32-36). The S. negevensis full length 16S and 23S rDNA sequences are each 80-87% 
identical to those of members of the Chlamydiaceae, whereas all members of the Chlamydiaceae 
have >90% identity with each other. Although the full genome sequence of S.negevensis has not 
been determined, partial DNA sequences of the RNase Pgene (rnpB) , mutS, and groEL have been 
determined from PCR amplified products using primers based on consensus sequences determined 
from several strains of chlamydia and other bacteria. Taxonomic relationships among 
chlamydiaceae species have been confirmed by analyses of GroEL ( the 60-kDa heat shock 
protein ), KDO transferase, the small cysteine-rich lipoprotein, the 60 kDa cysteine-rich protein, 
and the major outer membrane protein (MOMP)(21,22). 
Antigens and membrane structure 
The polypeptide pattern of simkania negevensis is significantly different from that of other 
members of the chlamydiales.  Only a relatively small number of common epitopes (most likely 
heat shock proteins) are shown to be shared when antigen panels of S.negevensis, Waddleia 
chondrophila, Parachlamydia acanthamoebae (23,24,25,26,27), C.trachomatis and Chlamydophila 
(Chlamydia) pneumonia (28,29,30,31) are tested for cross reactivity by western blot using specific 
polyclonal antisera (36,37,38,39,40).  
Immunoblot S.negevensis whole cell lysates and sarcosyl insoluble membrane preparations using 
hyperimmune murine sera showed the following predominant membrane fraction antigens:  asset of 
three bands migrating at 37-42kDa , additional bands at 26,52,58, and 64 kDa , and a slower 
migrating band at >100 kDa. Monoclonal antibodies (MAbs) prepared against whole organisms or 
whole cell lysates reacted mainly with the 37-to 42 kDa set of bands, indicating that the complex 
was strongly immunogenic. Some of these MAbs were capable of neutralizing S.negevensis in 
vitro, but were unable to neutralize C.trachomatis  under the same conditions.  
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When these MAbs raised against S.negevensis were tested by immunoblotting on C.trachomatis 
whole cell lysates or membrane preparations, they were able to recognize an epitope located on the 
OmpA protein. On the other hand ,Abs recognizing family-specific epitopes of chlamydial OmcB 
(OMP 2), OmpA(MOMP), and LPS did not bind S Negevensis antigens. The structure and the 
function of the three polypeptides belonging to the S negevensis outer membrane complex need to 
be further investigated. It may be that shared epitopes constitute part of a porin structure common to 
the Chlamydiaceae and S negevensis (40.41,42). 
Growth life cycle  
Simkania replicates in a biphasic life cycle similar to Chlamydia. Infection starts with an electron 
dense elementary body (0.2-0.3 m), which differentiates into the electron lucent replicative form 
called the reticulate body (0.3-0.7 m). The active replication cycle of Sn takes about 3–5 days and 
extensive long-term relationship with the host cell of about 10–15 days has been reported (Kahane 
et al, 2002). The strategy that this pathogen takes to keep its host alive for such a long period of 
time is unknown. Unlike other Chlamydiales (Kahane et al, 2002) observed that in Sn the 
replicative form may also be infective. This assumption was derived from the fact that they could 
observe similar kinetics of growth curve in less dense (RB) and more dense (EB) urografin 
fractions.  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 fig 1 . Detail of an Acanthamoeba trophozoite (Ac) harbouring different developmental stages of 
Simkania replicating within a membrane- bound vacuole (vm). The elementary bodies (eb) contain 
electron-dense nuclear material (N) and ribosomes. They are surrounded by the outer membrane 
(om) at some places separated from the inner cytoplasmic membrane (cm). They are considered as 
Gram-negative. The significantly larger reticulate stages (rb) have less dense fibrillar nuclear 
material and more ribosomes. They are also surrounded by an obviously more flexible trilaminar 
envelope. Transitory stages (ts) show intermediate traits between EBs and RBs. Remarkable are 
distinct ribosomes within the host’s cytoplasm which appear arranged like a string of pearls beneath 
the vacuolar membrane (arrowheads). Scale bar 0.25 µm. 
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intracellularly growing bacteria. Even at this low magni-
fication, at least two kinds of developmental stages of
the endocytobiont could be distinguished as exemplified
in Fig. 2, which shows even three stages. They are
located within an elongated, membrane-bound vacuole
of the host amoeba. Replication is performed by the
reticulate bodies, which finally transform via a transitory
stage (ts) to the elementary bodies representing the
infectious stage. The RBs containing numerous ribo-
somes appear pleomorphic with a flexible outer mem-
brane. The characteristic shape of the mature EBs is
quadr ngular or dumbbell-shaped. As far as we know,
this unique outline is different from the EBs of all other
Chlamydia-like acteria. Eb’s contain electron-dense
nuclear material (N) and ribosomes. They are enveloped
by the outer membrane, which may be separated from
the inner cytoplasmic membrane at some places. These
stages appear Gram-negative. The transitory stages
being still pleomorphic like the RBs already contain an
increasing amount of electron-dense nuclear matter. In
Fig. 2. Detail of an Acanthamoeba trophozoite (Ac) harbouring different developmental stages of Simkania replicating within a membrane-
bound vacuole (vm). The elementary bodies (eb) contain electron-dense nuclear material (N) and ribosomes. They are surrounded by the outer
membrane (om) at some places separated from the inner cytoplasmic membrane (cm). They are considered as Gram-negative. The significantly
larger reticulate stages (rb) have less dense fibrillar nuclear material and more ribosomes. They are also surrounded by an obviously more flexible
trilaminar envelope. Transitory stages (ts) show intermediate traits between EBs and RBs. Remarkable are distinct ribosomes within the host’s
cytoplasm which appear arranged like a string of pearls beneath the vacuolar membrane (arrowheads). Scale bar 0.25 µm.
For decades research progress has been hampered to fully understand the genetics of Chlamydiales 
as they are obligate intracellular pathogens, there is no means to genetically manipulate them. 
Recently (Wang et al, 2011) had discovered that foreign DNA could be introduced into the 
chlamydial inclusion by using calcium ions. This will pave way for the chlamydial genetics and 
could lead to the development of chlamydial vaccines and therapeutic interventions. 
Chlamydiales have a unique biphasic life cycle. Bedson and colleagues first observed these distinct 
particles when they examined psittacosis-infected tissue (Bedson et al 1932). Later the existence of 
these developmental forms confirmed under electron microscopic studies (Constable, 1959; 
Gaylord, 1954). The pathogen exists in two morphological forms namely elementary body (EB), 
which is infective, but metabolically inactive and reticulate body (RB), metabolically active and 
non- infective. The EB is 0.3 µm in diameter and RB around 1 µm. Infection is initiated by 
adherence of EB to the host cells through an unknown receptor that probably binds with heparan 
sulfate-like glycosaminoglycan present on the cell surface (Gutierrez- Martin et al, 1997; Kuo et al, 
1973). Several other ligands for Chlamydia binding have also been proposed, including Hsp70 and 
Omp2 (Joseph & Bose, 1991).  
Recent studies further revealed the crucial role of the cellular PDGF-receptor, the host kinase c- 
Abl, and the chlamydial protein Tarp (translocated actin recruiting phosphoprotein) in pathogen 
uptake (Clifton et al, 2004; Elwell et al, 2008). Together with other chlamydial effector proteins 
Tarp is translocated into the host cell via a type III secretion system (T3SS), a needle-like protein 
complex that spans the bacterial membranes (Subtle et al, 2000). Cytoskeleton rearrangements 
induce the uptake of the EB, which can also be seen in non-phagocytic cell (Jewett et al, 2008). 
After binding, the Chlamydia is internalized, enveloped within membrane-bound compartments that 
are subjected to bacteria induced modifications both in their luminal environment and in their 
membrane composition, and transported to a perinuclear location. These modified Chlamydia-
containing membrane compartments are termed inclusions. The bacteria appear to survive within 
lysosomes (Eissenberg et al, 1983; Scidmore et al, 1996a; Scidmore et al, 1996b) whereas the the 
inclusion in host epithelial cells through their ability to inhibit fusion between the inclusions and 
fusion to sphingomyelinrich vesicles is enhanced (Hackstadt et al, 1995). 
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 Figure 2 - Infectious EB adhere to the receptors on the host cell. Upon internalization, the 
chlamydial inclusion is formed where EB differentiate into RB, which replicate by binary fission to 
produce several hundred particles that re-differentiate into infectious EB which leave the cell in 
order to start a new round of infection. Under certain conditions, such as sub-lethal doses of 
antibiotics like penicillin, IFN-gamma stimulation or co-infection with virus, aberrant bodies can 
be formed to persist inside the host cell. Depending on the species, the developmental cycle is 
completed after 48-72 h or 5-8 days in tissue culture cell lines. 
Within the inclusions, the EB differentiates into RB, which synthesize proteins and their own DNA 
and RNA then replicate by binary fission to form micro-colonies within the inclusion bodies. 
Differentiation of an EB into RB involves an increase in size, reduction of disulphide links in the 
outer membrane, unraveling of DNA in the condensed nucleoid and appearance of granular 
ribosomes (Wang et al, 1994). The initial signal for the differentiation of EB into RB is not known. 
By 18 hours postinfection (hpi), a proportion of the developed RB begins to transform back into EB 
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Figure 1.2. Infectious EB adhere to the receptors on the host cell. Upon internalization, the chlamydial 
inclusion is formed where EB differentiate into RB, which replicate by binary fission to produce several 
hundred particles that re-differentiate into infectious EB which leave the cell in order to start a new 
round of infectio . Under certain condi ions, such as sub-lethal doses of antibiotics like penicillin, IFN-Ȗ 
stimulation or co-infection with virus, aberrant bodies can be formed to persist inside the host cell. 
Depending on the species, the developmental cycle is completed after 48-72 h or 5-8 days in tissue 
culture cell lines. 
Within the inclusions, the EB differentiates into RB, which synthesize proteins 
and their own DNA and RNA then replicate by binary fission to form micro-colonies 
within the inclusion bodies. Differentiation of an EB into RB involves an increase in 
size, reduction of disulphide links in the outer membrane, unraveling of DNA in the 
condensed nucleoid and appearance of granular ribosomes (Wang et al, 1994). The 
initial signal for the differentiation of EB into RB is not known. By 18 hours post 
while the remainder continues to divide in the growing inclusion (Hackstadt et al, 1999) within 24 h 
large inclusions are formed. Between 24 and 72 hpi the RB redifferentiate into EB and are released 
into the extracellular space by rupturing the cells to start a new round of infection (Moulder, 1991) .  
As the RB is not infectious, re-differentiation into EB is an essential step in the chlamydial 
developmental cycle for the establishment of an acute infection. The engagement of the chlamydial 
type III secretion system in RB to EB re-differentiation was recently discussed by (Peters et al, 
2007). The environmental signal that induces the reorganization from RB to EB is undefined. In the 
presence of Interferon , virus infection or antibiotics like penicillin the chlamydial particles gets 
stuck reversibly in the persistence stage where only aberrant bodies are observed. Persistence is the 
viable but non-cultivable growth stage of Chlamydia where it maintains long term relation with the 
host cells (Hogan et al, 2004). Depending on the species and the amount of bacteria that entered the 
cell, the developmental cycle of C. trachomatis, C. pneumonia and Simkania negevensis in cultured 
cell lines is completed after 48 h, 72 h and 5 days, respectively. 
Antibiotics and cytokine sensitivities 
Although in its sensitivity to macrolides and tetracyclines S negevensis is similar to the chlamydia, 
unlike these cousins, it is totally resistant to penicillin, and indeed, is routinely grown in the 
presence of penicillin. While penicillin and other beta lactams are not the drugs of choice for 
treatment of chlamydial infections, in vitro the organisms are sensitive to the presence of these 
drugs, and their development is inhibited at the reticulate body stage in the presence of beta 
lactams. S negevensis was found to be resistant to bacitracin, but sensitive to D-cycloserine; both 
these drugs are inhibitors of peptidoglycan synthesis. Hybridization experiments using cloned C 
trachoma tis penicillin binding protein DNA as probes indicated the presence of homologous DNA 
in S negevensis. Whether S negevensis “penicillin binding proteins “ are not transcribed or have no 
penicillin binding sites still remains to be investigated. preliminary experiments indicate that 
azithromycin, minocycline and erythromycin are the most effective inhibitory and bactericidal 
drugs in cycloheximide treated Vero cells.  
S.negevensis is resistant to high concentrations of interferon gamma when grown in HEp-2 cells 
and inhibited by concentrations of tumor necrosis factor (TNF alpha)(43,44,45).  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Seroprevalence 
The seroprevalence of S. negevensis in the population shows significant variations in different parts 
of the world, where it is seen as a high percentage of 55-80% in Israel, but also a low percentage as 
4% in Japan. These differences may be partly due to the sensitivity and specificity of the 
approaches used serological and the cut-off for positivity established (46). The involvement of S. 
negevensis in respiratory tract infections has been studied in different cohorts of patients in Europe, 
the Middle East and America using serological or molecular diagnostic methods. Some of these 
studies report an association between S. negevensis and community-acquired pneumonia (CAP), 
exacerbation of chronic obstructive pulmonary disease and (COPD) and bronchiolitis in adults and 
children . 
The role of this bacterium as the causative agent of CAP is, however, difficult to assess and, for this 
reason, further work is needed to clarify the epidemiological and serological importance of this 
organism at the clinical level. 
The incidence of S. negevensis could be higher than that observed in some populations or ethnic 
groups, in the presence of concentrations of the microorganism undetectable to the diagnostic 
methods used. It was documented a high seroprevalence of S. negevensis, in studies in the Middle 
East (the Bedouins) and in northern Canada (in Inuit). 
A study carried out in Brooklyn (NY), in contrast, did not show any association of S. negevensis 
with respiratory problems, despite the high prevalence (23.5%) of antibodies against S. negevensis 
in adults and children of this population, assuming that these bacteria like Chlamydia are simple 
colonizers (diners). Therefore, a thorough assessment of the pathogenic role of S. negevensis is 
necessary (47). 
It was also studied the possible involvement of S. negevensis other breathing disorders, such as 
chronic cough or asthma, but the data in this regard are still doubts . 
In one study, S. negevensis was sought through the molecular method of PCR in samples of 
bronchoalveolar lavage of patients undergoing lung transplantation, showing surprisingly high 
prevalence of this microorganism of 97.5% (compared to 14% in patients highlighted undergoing 
transplantation of other solid organs) with a possible association with acute rejection. In fact, 59% 
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of patients positive in PCR, for S. negevensis, in comparison to 30% of patients with rejection but 
results PCR negative for S. negevensis (48). 
A further study highlights the fact that hospitalized patients exposed to aerosol particles, such as 
mechanical ventilation, could thus be colonized or infected by this intracellular bacterium, whose 
pathogenic role in this environment was investigated at the time, very little . 
They are very interesting studies performed in vitro to understand the pathogenesis of infections 
with S. negevensis: in these studies was demonstrated the ability of the microorganism infecting 
human macrophages and induce an inflammatory response (48).  
Infections on human  
Despite advances in antibiotic therapy, pneumonia remains one of the leading infectious causes of 
death in developed countries and a major cause of morbidity, especially in the elderly population 
and among patients with chronic underlying diseases (Mandell et al., 2007). Although a broad 
spectrum of microbial pathogens have been recognized as causal agents of respiratory tract 
infections (RTIs), the offending microorganism remains unknown in about half of the cases of 
community-acquired pneumonia (CAP) (Bochud et al., 2001; Echols et al., 2008), and three 
quarters of the cases of nosocomial pneumonia (Costa et al., 2001). 
Microorganisms causing pneumonia may be acquired from respiratory droplets through human-to-
human con- tact or from aerosolized particles from an animal or environmental reservoir. The 
epidemiology of RTI thus strongly depends on the interactions between humans and their ecosystem 
and evolves according to environmental changes due to human activities, climatic or ecological 
perturbations. Pandemics of influenza or the emergence of new respiratory diseases such as severe 
acute respiratory syndrome are dramatic illustrations of these phenomena. 
Free-living amoebae live in water, soil and at the water–air interface. As they generally use bacteria 
as their main nutritional source, they are especially present in large quantities in sediments and 
biofilms (Rodriguez-Zaragoza, 1994). Thus, humans have been increasingly exposed to amoebae 
and to their related bacterial pathogens with the progressive development of various modern man-
made water systems such as water-treatment plants, cooling towers, air conditioners, humidifiers, 
spas and swimming pools. Apart from L. pneumophila, which has mainly been recognized due to 
the dramatic importance of the Philadelphia outbreak, many other bacteria that resist the phagocytic 
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amoebae may also use these protists as widespread reservoirs and may have acquired virulence 
traits promoting their resistance to macrophages. Interestingly, some of these amoebae-resisting 
bacteria have also been discovered during outbreaks of RTI (Herwaldt et al., 1984; Birtles et al., 
1997). Indeed, given their intracellular lifestyle, they either do not grow or only poorly grow in 
conventional axenic media. It is important that the microbiology community be well aware of these 
new emerging human agents of pneumonia and develop new diagnostic tools for their 
identification. Amoebal coculture and amoebal enrichment coupled with detection of potential intra- 
amoebal bacteria have been demonstrated to be largely successful in identifying a large biodiversity 
of new pathogens from patients (Corsaro et al., 2009). 
Simkania negevensis may easily grow within the Acanthamoeba amoeba and may also use free-
living amoebae as a widespread environmental reservoir. Simkania negevensis was first described 
in 1993 as a cell culture contaminant of unknown origin exhibiting a typical two-stage 
developmental cycle, with infectious elementary bodies and replicative reticulate bodies, but 
differing significantly from Chlamydiaceae (Kahane et al., 1993). Its seroprevalence in the 
population displays important variations around the world, having been reported to be as high as 
55–80% in Israel and only 4% in Japan. These differences may be partially due to the respective 
sensitivity and specificity of the serological approaches used and to the cut-off defining positivity. 
The involvement of S. negevensis in RTIs has been investigated in several large cohorts of patients 
in Europe, the Middle East and America using serological or molecular diagnostic methods 
(Nascimento- Carvalho et al., 2009). Some of these analyses reported an association with CAP, 
exacerbations of chronic obstructive pulmonary diseases or bronchiolitis in adults and children. The 
importance of this bacterium as a causal agent of CAP is, however, difficult to evaluate and seems 
relatively marginal (o 2% of all aetiologies) in view of these results. Its incidence may be higher in 
some populations or ethnic groups where a high seroprevalence of S. negevensis has been 
documented, for example in the Middle East (Bedouins) or Northern Canada (Inuits) (Greenberg et 
al., 2003), whereas it remains to be determined in many other parts of the world. A study carried out 
in Brooklyn (NY) deserves mention as it did not identify any association with respiratory diseases 
despite a high prevalence (23.5%) of antibody titers against S. negevensis among adults and 
children in this population, suggesting that these Chlamydia-related bacteria are simple colonizers. 
Thus, thorough evaluation of the pathogenic role of S. negevensis is warranted, as most studies did 
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not include a control group, and among the few studies with a control group, most failed to 
demonstrate a significant correlation with lower RTIs. 
The implication of S. negevensis in other respiratory diseases, such as chronic cough or asthma, has 
also been investigated and could not be demonstrated conclusively (Korppi et al., 2006). In one 
study, S. negevensis was detected by a PCR method in bronchoalveolar lavage samples of lung 
transplant recipients with a surprisingly high prevalence (97.5%, when compared with only 14.1% 
in other solid-organ transplant recipients; P o 0.0001) (Husain et al., 2007). Many of these patients 
did not have documented pneumonia and the pathogenic role of S. negevensis in this context thus 
remains unclear. The authors of this study postulated a possible role in acute graft rejection, 
although the analysis was underpowered to reach statistical significance. Like other Chlamydia-
related organ- isms, S. negevensis may infect free-living amoebae such as Acanthamoeba which are 
widespread in water, including hospital water supplies (La Scola et al., 2002). Hospitalized patients 
exposed to aerosolized particles, such as those undergoing mechanical ventilation, may thus be 
colonized or infected by these intracellular bacteria, whose pathogenic role in this setting has been 
poorly investigated. However, it is worth noting that in vitro studies of the pathogenesis of S. 
negevensis have demonstrated its ability to infect human macrophages and to induce a host cell 
inflammatory response, supporting its potential ability to cause human infections and the need for 
further clinical investigations. 
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table 1_ Simkania negevensis as causal agents of pneumonia: review of literature. 
Pathogenic potential of emerging chlamydiae  
Free-living amoebae such as Acanthamoeba and Hartmannella play a key role as reservoirs and/or 
vectors for a variety of amoeba-resisting microorganisms (49), including the chlamydiae. 
Acanthamoeba is a suitable host for most Parachlamydiaceae (50,51) and S. negevensis (52,53), 
whereas Hartmannella, Balamuthia, Dictyostelium, and Naegleria are also able to sustain infection 
by some Parachlamydiaceae (54,55), S. negevensis (56), and Waddlia chondrophila (55). Various 
interactions between chlamydiae and amoebae may take place, depending on the chlamydial and the 
amoebal species and strain and on environmental conditions. Thus, P. acanthamoebae is 
endosymbiotic at 25 to 30°C and lytic at 32 to 37°C for Acanthamoeba spp.. Since the temperature 
of the human nasal mucosa is generally lower (about 30°C) than that of the lower respiratory tract 
(generally between 35 and 37°C), P. acanthamoebae could reside symbiotically within amoebae 
present on the nasal mucosa and induce the lysis of the amoebae that reach the lower respiratory 
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high prevalence (23.5%) of antibody titers against S. nege-
vensis among adults and children in this population, sug-
gesting that these Chlamydia-related bacteria are simple
colonizers (Kumar et al., 2005). Thus, thorough evaluation
of the pathogenic role of S. negevensis is warranted, as most
studies did not include a control group, and among the few
studies with a control group, most failed to demonstrate a
significant correlation with lower RTIs (Table 2).
The implication of S. negevensis in other respiratory
diseases, such as chronic cough or asthma, has also been
investigated and could not be demonstrated conclusively
(Johnsen et al., 2005; Kumar et al., 2005; Korppi et al., 2006).
In one study, S. negevensis was detected by a PCR method in
bronchoalveolar lavage samples of ung transplant recipients
with a surprisingly high prevalence (97.5%, when compared
with only 14.1% in other solid-organ transplant recipients;
Po 0.0001) (Husain et al., 2007). Many of these patients did
not have documented pneumonia and the pathogenic role
of S. negevensis in this context thus remains unclear. The
authors of this study postulated a possible role in acute graft
rejection, although the analysis was underpowered to reach
statistical significance. Like other Chlamydia-related organ-
isms, S. negevensis may infect free-living amoebae such as
Acanthamoeba which are widespread in water, including
hospital water supplies (La Scola et al., 2002; Thomas et al.,
2006). Hospitalized patients exposed to aerosolized parti-
cles, such as those undergoing mechanical ventilation, may
thus be colonized or infected by these intracellular bacteria,
whose pathogenic role in this setting has been poorly
investigated (La Scola et al., 2002). However, it is worth
noting that in vitro studies of the pathogenesis of
S. negevensis have demonstrated its ability to infect human
macrophages and to induce a host cell inflammatory re-
sponse, supporting its potential ability to cause human
infections and the need for further clinical investigations
(Kahane et al., 2008, 2007).
Parachlamydiaceae
This family has drawn increasing attention in the last decade
because of the potential pathogenicity of it first recognized
member, P. acanthamoebae, which was identified as the
cause of outbreak of fever of undetermined origin
occurring in Vermont in 1989 (Birtles et al., 1997). An
amoeba of the Acanthamoeba genus was isolated from the
water of a humidifier and was subsequently shown to be
infected with a gram-negative bacterium termed Hall’s
coccus. This organism was characterized by comparative
sequence analyses (Birtles et al., 1997) and was found to be
similar to a Chlamydia-like endoparasite of Acanthamoeba
(strain Bn9) previously identified in the nasal mucosa of
healthy subjects (Amann et al., 1997). Hall’s coccus and
strain Bn9 were subsequently assigned to the species
P. acanthamoebae within the Chlamydiales order (Everett
Table 2. Simkania negevensis as causal agents of pneumonia: review of the literature
Population (country) and
number of patients Disease Diagnostic method
Positive
results
P value
(if controls)
Recent infection!
and no alternative
pathogen References
Adults (Israel) 308 CAP Serology (IgG, IgA) 112 (37%) No control 4 (1.3%) Lieberman et al. (1997)
Infants (Israel) 239 Bronchiolitis Culture and/or PCR
(NP swabs)
60 (25%) Po 0.001 38 (16%) Kahane et al. (1998)
Adults (Israel) 190 COPD
exacerbation
Serology (IgG, IgA) 120 (63%) Not significant 1 (0.5%) Lieberman et al. (2002)
Infants (Canada) 22 Bronchiolitis PCR (NP swabs) 14 (64%) No control 2 (9%) Greenberg et al. (2003)
Adults/children (USA) 188 Bronchiolitis,
Pneumonia
Serology (IgG) (n=69) 14 (18%) Not significant NA Kumar et al. (2005)
Asthma PCR (NPl swabs)
(n=169)
29 (17%) Not significant NA
Adults (UK) 29 RTI Serology (IgG) 18 (62%) Not significant NA Friedman et al. (2006)
Serology (IgA) 5 (17%) P=0.004 NA
Children (UK) 222 Bronchiolitis Culture and/or PCR
(NP swabs)
111 (50%) No control NA Friedman et al. (2006)
Children (Italy) 101 CAP Serology (IgM, IgG) 20–30% No control 2 (2%) Fasoli et al. (2008)
Children (Finland) 174 CAP Serology (IgM) 18 (10%) No control 6 (3.4%) Heiskanen-Kosma et al.
(2008)
Children (Brazil) 184 CAP Serology (IgM, IgG) 3 (1.6%) No control 1 (0.5%) Nascimento-Carvalho
et al. (2009)
!Recent infection was defined as: serological evidence for recent infection (positive IgM or significant increase between initial and convalescent IgG
titres) or positive PCR result during the course of infection.
COPD, chronic obstructive pulmonary disease; NA, data not available.
FEMS Microbiol Rev 34 (2010) 260–280 c! 2010 Federation of European Microbiological Societies
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tract, inducing their own release and possibly starting an infectious process. Conversely, the 
virulence of the amoebae could be increased when harboring chlamydiae. 
Free-living amoebae, mainly Acanthamoeba spp., have been shown to be natural hosts for several 
amoeba-resisting bacteria, including Parachlamydiaceae. These unicellular eukaryotes have also 
been successfully used in a cell culture system to isolate a variety of amoeba-resisting bacteria from 
clinical samples . 
The fact that C. pneumoniae and S. negevensis are able to infect Acanthamoeba in vitro and the fact 
that free-living amoebae likely play a role as an environmental host of Simkania support the use of 
Acanthamoeba to isolate novel chlamydiae from clinical samples. Of note, Neochlamydia 
hartmannellae  (but not other Neochlamydia spp. , has been successfully grown within 
Hartmannella vermiformis but not within Acanthamoeba. Moreover, Waddlia chondrophila may 
grow in Acanthamoeba and other free-living amoebae, but only after subcultivation in H. 
vermiformis. Efforts to cultivate Fritschea in Acanthamoeba have failed. In addition, experimental 
studies have shown that  a wide diversity of free-living amoebae are able to sustain the growth of 
the new chlamydiae and not all strains of a free-living amoeba species are susceptible to infection 
by these agents. This should be taken into account when interpreting negative coculture results. 
Thus, the use of more than one strain of Acanthamoeba and/or the use of several amoeba species 
(e.g., Acanthamoeba and Hartmannella) is recommended to increase the rate of isolation of 
chlamydiae, at least from clinical samples that give a positive PCR result. In addition to the possible 
problem of a persistent viable but noncultivable stage, false-negative culture may also occur due to 
the use of a cell that is not permissive to a given species (i.e., Neochlamydia and Acanthamoeba) or 
due to the presence of antibiotics in the amoebal coculture to which the bacterium is susceptible. 
False-positive results might occur if the cell line is contaminated with an endosymbiotic chlamydia 
(which will not be easily detected) or if the broth is not adequately filtered and/or heat sterilized. 
Since amoebae may harbor Parachlamydiaceae, S. negevensis, and Waddlia chondrophila , it may 
be useful to first isolate amoebae from clinical samples and then look within these amoebae for 
whether a chlamydia is present. Screening of environmental samples for the presence of amoebae 
may also contribute to the identification of a possible source of infection (e.g., humidifiers or air 
conditioning systems). Amoebal enrichment may be performed using established protocols 
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Specimens are generally seeded on nonnutrient agar preinoculated with heat-inactivated Escherichia 
coli. 
 
fig 3 overview of an infected Acanthamoeba, strain HLA, jammed with numerous organisms of 
simkania negevensis (arrows) as a result of multiplication of the endoparasite  in a period of six 
days. Scale bar 1.0 microm.  
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with the ba teria-rich suspension (Table 2). As a result
of the testing of 8 strains belonging to 6 different genera
only Hartmannella vermiformis, strain Os101 and
Balamuthia mandrillaris grown in SCGYE-medium
proved positive within a period of 3-4 days. In addition
to the confirmation of a cytoplasmatic infection with
Simkaniae as seen by phase contrast microscopy, both
strains of these unrelated amoebae lost their ability to
form cysts, which proves that they were actually in-
fected. These associations of amoebal hosts and
endocytobionts turned out to be stable infections over
many passages. Since the trophozoites of Balamuthia
began shedding elementary bodies 3 to 5 days post
infection, they survived because they could not be
overgrown by the endoparasites. The number of ex-
pelled EBs in the medium increased to such an extent
that this host-parasite combination was suited perfectly
for mass production of EBs as the infectious stages of
Simkania. In contrast, strains of Willaertia magna, a
second Hartmannella strain designated C3/8, and two
strains of the cellular slime mould Dictyostelium were
resistant to infection. The same was true for Naegleria
lovaniensis and Acanthamoeba strain C3, infection of
which had been attempted by cocultivation with the
protozoa-adapted Simkania cells.
Electron microscopy. Acanthamoebae of strain HLA
were fixed on the 6th day after infection with a suspen-
sion of Simkania stages from BGM-cell culture. Elec-
tron microscopy revealed heavily infected trophozoites
which were jammed with organisms belonging to differ-
ent stages of the Chlamydia-like developmental cycle
(Fig. 1). This reflects the high replication rate of these
Fig. 1. Overview of an infected Acanthamoeba, strain HLA, jammed with numerous organisms of Simkania negevensis (arrows) as a result of
multiplication of the endoparasite in a period of six days. Scale bar 1.0 µm.
Aim of the project  
Intracellular bacterial pathogens may have a variety of relationships with their hosts, leading either 
to acute or to chronic infections, and resulting in short term or long term pathologies. A novel 
approach to learning more about the potential pathogenesis of S.negevensis is to examine in vitro 
which types of epithelial cells it is able to infect, and which of these it may activate to inflammatory 
citokine secretion(56).  
Because of its ability to assume persistent forms of infection, which may lead to a prolonged 
inflammatory response, Simkania, may be involved in pathologic complications. 
Free-living amoebae such as Acanthamoeba and Hartmannella play a key role as reservoirs and/or 
vectors for a variety of amoeba-resisting microorganisms, including the chlamydiae. 
Since amoebae may harbor Parachlamydiaceae, S. negevensis , and Waddlia chondrophila, it may 
be useful to first isolate amoebae from clinical samples and then look within these amoebae for 
whether a chlamydia is present. Screening of environmental samples for the presence of amoebae 
may also contribute to the identification of a possible source of infection (e.g., humidifiers or air 
conditioning systems). 
Transmission of SN is probably by droplet or close contact, but there is evidence that water supplies 
are also implicated, and this was subject of this study (currently under way). According to a recent 
study (57) was showed a seroprevalence of IgG and IgA anti S. negevensis significantly higher , not 
only in patients with respiratory diseases , but also in patients with gastrointestinal disorders 
compared to the healthy population. Since S. negevensis survives and multiplies within amoebae 
and has been highlighted in the sources and collected water , has been suggested for patients we 
studied a way of oral transmission of the infection, in addition to that already known via aerosol or 
closely. 
The main purpose of this study was to evaluate the impact of S. negevensis population of 
hemodialysis patients and carriers of kidney transplant, to study correlations between clinical events 
( gastrointestinal and respiratory symptoms ) and positive test for the infection, search correlation 
between infection and laboratory indices ( indices of nonspecific inflammatory and non- 
differential, transaminases ). 
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On the subject of transplantation is also important to open a debate on a worldwide basis over the 
fact that the infection can be S.negevensis, as other pathogens, closely related to the acute rejection 
of transplanted lungs. 
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Samples and methods 
We studied 111 patients with kidney transplants, and 112 patients undergoing hemodialysis. Were 
collected the personal data, age, sex, height, weight, the underlying disease for which there has been 
the chronic renal failure.  
From the laboratory point of view were collected such data: the values of creatinine, the presence or 
absence of proteinuria, hemoglobin values, transaminases, complete blood count with differential, 
the non-specific inflammatory markers (ESR, CRP). It was collected complete clinical history . 
Were investigated any respiratory and gastrointestinal symptoms at the time of withdrawal.  
Have been investigated IgG and IgA anti Simkania negevensis in serum samples of patients on 
dialysis and patients undergoing kidney transplantation. 
Were analyzed waters network used for hemodialysis before and after the treatments disinfectants: 
sampled and tested for the presence of S.negevensis . 
Cultivation of C. pneumoniae and S. negevensis 
The reference strain of S. negevensis ZT ( ATCC VR- 1471 ) and the reference strain IOL- 207 of 
C. pneumoniae were grown in LLC - MK2 cells (continuous line coming from monkey kidney ) , 
cultured in sterile flasks in the presence of soil , Eagle MEM ( Minimal Essential Medium ) . 
For the culture of cells were added to a series of substances to the soil , such as fetal bovine serum 
(SBF ) , glucose, L - glutamine and also antibiotics and antifungal agents ( to prevent the growth of 
other bacteria and / or fungi) as vancomycin , gentamicin and fungizone( inactive against the two 
microorganisms ) . 
To encourage the growth of S. negevensis and C. pneumoniae to the growth medium , containing 
higher concentrations of drugs , glucose and SBF respect to the ground for cell culture , 
cycloheximide has been added that , by slowing down the cellular metabolism , increases the 
infectivity elementary bodies ( 33 ) . The concentrations of the various substances added to soil is 
shown in Table . 
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 For S. negevensis was used RPMI ( Roswell Park Memorial Institute ) and C. pneumoniae soil 
Eagle MEM ( Minimal Essential Medium ) .  
The flasks containing the cell suspensions were incubated for 48-72 hours in a thermostat at 37 ° C 
in the presence of 5 % CO2. After the formation of the monolayer , the cells were detached from the 
flask with trypsin - EDTA and resuspended in growth medium and again , so as to obtain a 
concentration of 100.000 cells / ml . The cell suspension was distributed in plastic tubes with screw 
cap , containing a glass slide on the bottom of 1 cm in diameter , in the amount of 1 ml of cell 
suspension / tube. The test pieces were put back into the incubator so as to obtain 100,000 cells / 
slide after about 24 hours of incubation . The next day , the tubes were infected with C. pneumoniae 
and S. negevensis . Before infecting the cell monolayer was removed the growth medium of the 
cells and replaced with 1 ml of suspension of S. negevensis or C. pneumoniae . To facilitate the 
infection , and the entrance of micro-organisms within the cells , the tubes were centrifuged at 3000 
rpm for 3 hours , at a temperature of 33 ° C and then placed to incubate in a thermostat at 37 ° C in 
the presence of 5 % CO2 . Given the different duration of the development cycle of C. pneumoniae 
and S. negevensis , the monolayers infected with C. pneumoniae have been made incubate for 3 
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  Terreno Eagle MEM 
per cellule (ogni 500 
ml) 
Terreno Eagle MEM per C. 
pneumonia e (500 ml) 
 Terreno RPMI 
per S. negevensis 
(500ml) 
SBF (inattivato a 56°C 
per 30 minuti) 
50 ml 100 ml 75 ml 
L-glutammina 
(200mM) 
5 ml 5 ml 5ml 
Glucosio 6 ml (5,94 gr/100 ml 
H2O) 
2 gr 4 g 
Fungizone 0,15 (µg/ml) 1 ml (1 µg/ml) 1 ml (2 µg/ml) 
Vancomicina 0,5 ml (10µg/ml) 5 ml (10µg/ml) 8 ml (160 µg/ml) 
Gentamicina 0,125 ml (40µg/ml) 0,6 ml (40µg/ml) 1,2 ml (100 µg/ml) 
Cicloeximide (1µg/ml)  0,7 ml  0,7 
 
Tabella 2. Concentrazioni e quantità delle diverse sostanze aggiunte ai terreni di coltura.  
 
Per S. negevensis è stato utilizzato il terreno RPMI (Roswell P rk Memorial 
I stitute) e per C. pneumoniae il terreno Eagle MEM (Minimal Essential Medium).  
Le fiasche, contenenti le sospensioni cellulari, sono state poste ad incubare per 48-72 
ore in termostato a 37°C in presenza del 5% di CO2. Dopo la formazione del 
monostrato, le cellule sono state staccate dalla fiasca con tripsina-EDTA e risospese 
e nuovamente in terreno di crescita, in modo da ottenere una concentrazione di 105 
cellule/ml. La sospensione cellulare è stata ripartita in provette di plastica con tappo 
a vite, contenenti sul fondo un vetrino di 1 cm di diametro, nella quantità di 1 ml di 
sospensione cellulare/provetta. Le provette sono state messe nuovamente in 
i cubatore in modo da ottenere 100.000 cellule/v trino dopo circa 24 ore di 
incubazione. Il giorno successivo, le provette sono state infettate con S. negevensis e 
C. n umoniae. Prima di inf ttar  il monostrato cellulare è stato rimosso il terreno di 
crescita d ll  cellule e sostituito con 1 ml di sospension  di S. negevens s o C.
pneumoniae. Per favorire  l’infezione,  e  l’ingresso  dei  microrganismi  all’interno  delle  
cellule, le provette sono state centrifugate per 3 ore a 3000 rpm, alla temperatura di 
33°C e successivamente poste a incubare in termostato a 37°C in presenza del 5% di 
CO2. Data la durata diversa del ciclo di sviluppo di C. pneumoniae e S. negevensis, i 
days while those infected with S. negevensis for 5 days. To check the degree of infectivity was 
performed by direct immunofluorescence staining in the case of C. pneumoniae and indirect for S. 
negevensis . 
In this regard , the soil was removed accretion inside of the tubes and replaced by methanol , which 
was left on for 5 minutes to allow the attachment of the cells .  
For direct staining of C. pneumoniae , the monolayer was put into contact with monoclonal 
antibodies directed against the LPS of chlamydia , conjugated to fluorescein , and left to incubate 
for 30 minutes in pan moist at 37 ° C . After incubation has been carried out a quick wash in 
distilled H2O and the slides were mounted with glycerin. For staining of S. negevensis , instead , 
the monolayer , always after fixing with methanol , was put in contact with the monoclonal 
antibody D5-14 produced in our laboratory and reactive against a surface protein of 64-66 kDa S. 
negevensis . After an incubation for 40 minutes in pan moist at 37 ° C , were carried out washing 
with H2O and PBS , and then was added the secondary antibody anti - mouse immunoglobulins 
conjugated with fluorescein diluted 1/30 . Incubation for 30 minutes in pan moist at 37 ° C , 
followed by additional washes and finally to the monolayer was added Evans blue for a minute so 
as to dampen the background fluorescence and the slides were mounted with glycerin. At this point 
it was possible to monitor fluorescence microscopy infectivity in cell monolayers , S. and C. 
pneumoniae negevensis , noting the number of green fluorescent cytoplasmic inclusions present 
compared to the cell nuclei and uninfected cells stained red. The evaluation of the degree of 
infectivity (number of inclusions present ) allows to calculate the appropriate dilution of S. 
negevensis or C. pneumoniae in such a way as to obtain , in the next step into new cells , the 100 % 
of infectivity.  
At this point , to obtain large quantities of cells infected with C. pneumoniae or S. negevensis , the 
tubes with the infected monolayers were stirred for at least 1 minute vortexing ( in order to detach 
the monolayer from the slide ) and the suspension with infected cells , appropriately diluted with the 
suitable medium according to the microorganism , was inoculated in 30 -well plates at 6 to the 
bottom plane containing cell monolayers , in the amount of 4 ml / well . The plates were then placed 
in centrifuge at 2000 rpm for 2 hours at 33 ° C and subsequently left in an incubator for 3 or 5 days 
to allow growth of C. pneumoniae or S. negevensis respectively (58,59,60). 
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Purification of the elementary bodies of C. pneumoniae and S. negevensis 
The elementary bodies ( EC ) of S. pneumoniae and C. negevensis were purified sucrose gradient 
following the procedure Fukushi and Hirai , with appropriate modifications. After 3 or 5 days post 
infection , the infected cell monolayer was detached from the plates using sterile rubber and 
collected in 50 ml tubes , and kept in ice. The suspension was sonicated 3 times at low intensity for 
15 seconds , so as to break the cell membranes and release the micro-organisms and then 
centrifuged at 3000 rpm for 10 minutes at 4 ° C . The supernatant recovered , this has been allocated 
to ultracentrifuge tubes and centrifuged at 18,000 rpm for 35 min at 4 ° C , with maximum 
acceleration and deceleration . Once the pellet , removing the supernatant , it was resuspended in 40 
ml total Tris buffer ( 0.01 M , pH 7.4 ) , sonicated two times for 15 seconds and layered over a 
cushion of 8 ml of sucrose to 30 % in Tris Buffer , and then ultracentrifuged at 18000 rpm for 40 
minutes at 4 ° C , with minimum acceleration and deceleration . After centrifugation the pellet was 
resuspended in 2 ml of Tris buffer , sonicated 1 time for 10 seconds and placed gently on 30-60 % 
sucrose gradient in Tris . The gradient was previously obtained by slowly passing , with a peristaltic 
pump , 14 ml of 60 % sucrose solution in TRIS and 14 ml of the 30% in a test tube to 
ultracentrifuge . The subsequent centrifugation was carried out at 18000 rpm for 50 minutes at 4 ° C 
, with minimum acceleration and deceleration . The gang of EC was then collected with a syringe , 
and resuspended in about 30 ml of Tris then centrifuged at 18000 rpm for 35 minutes at 4 ° C , with 
maximum acceleration and deceleration . The EC present in the pellet were resuspended in 250-300 
L of Tris buffer , sonicated 1 time for 10 seconds , divided into small aliquots of 10 l each and 
stored at -70 ° C until use . 
Enzyme immunoassay ' home -made ' 
The enzyme immunoassay we used was that developed previously for the detection of antibodies 
against C. psittaci  (35). The protein concentration of the EB was determined using the Bio-Rad 
protein assay kit ( Bio-Rad , Richmond, CA ) with bovine serum albumin as a standard. The EC of 
elementary S. negevensis or C. pneumoniae , previously purified , were diluted , in order to obtain a 
final concentration of 1 mg / ml in Coating Buffer PBS with 0.03M 0.068M Sodium Carbonate and 
Sodium Bicarbonate , pH 9.4-9.8 ) and dispensed in amounts of 100 µl / well in a 96 well 
microplate.  
 27
The plate was kept overnight in pan moist at 4 ° C . The next day , the plate was turned upside 
down to empty the wells and were added to each well 200 L of blocking solution of 5% milk in PBS 
-Tween - EDTA . After incubation for 1 hour at room temperature , 5 washes were carried out over a 
period of 10 min with 200 L of PBS-Tween - EDTA / well . Subsequently , were dispensed 200 L of 
1% milk in PBS -Tween - EDTA to which were added 2 L of serum of patients to be examined so as 
to obtain a dilution of each serum of 1/100 for both research IgG that IgA anti - S . negevensis or C. 
pneumoniae .  
The plate was then left in incubation for 1 hour at 37 ° C , and then washed again as described 
above . At this point , were added 100 L of a polyclonal serum anti - human IgG or IgA (produced 
in rabbits) conjugated with peroxidase and diluted 1/500 in PBS -Tween - EDTA in each well of the 
plate . After incubation for 1 hour at 37 ° C , were carried further washing and finally added to the 
wells 100 L of tetramethylbenzidine (substrate specific for the enzyme ) . The reaction was finally 
stopped after about 10 minutes, adding to the wells 100 L of stop solution. The absorbance of the 
samples examined was read in a spectrophotometer at a wavelength ( λ ) of 450 nm against 620 nm 
reference .  
A serum sample was defined as positive when presented a value in optical density of at least two 
standard deviations above the average of 20 samples negative .  
In addition, two control sera testing positive MIF for S. negevensis and two for C. pneumoniae were 
included in each experimental session ELISA. Each assay was performed in duplicate (61). 
 28
Results 
Table 1 shows the comparisons between patients positive and negative results with the test for 
simkania and laboratory data . 
Analyzing the test for simkania ( positive and negative ) was observed statistical significance of 
positive than negative towards certain laboratory parameters : ESR , white blood cells and 
specifically the neutrophils ( VES p < 0.037 ; GB p < 0.038 ; neutrophils p < 0.018 ) . Non-
parametric test was performed according to the method of Kruskal-Wallis . 
Table 1. Comparisons between subjects positive and negative subjects to Simkania 
Nonparametric test because the distributions are not normal . 
ESR : the medians differ statistically significantly ( 25.00 vs. 39.00 )  
GB : medians differ statistically significantly ( 6:09 vs. 7:29 ) 
N : the medians differ statistically significantly ( 3:42 vs. 4.5) 
Totale 
soggetti
Simkania
Kruskal-Wallis, 
p-value
Negativo Positivo
Mean Median Minimum Maximum Mean Median Minimum Maximum
Kt/v 63.80 66.05 23 80 66.83 66.15 59 74 0.448
età 58.39 58.50 19 90     \
anni 
trapianto
6.67 4.00 1 30 10.56 12.00 1 22 0.118
Creatiniemia 3.96 1.89 1 15 5.23 4.70 1 11 0.135
Proteinuria 37.59 0.00 0 412 48.00 0.00 0 300 0.885
Hb 317.21 11.80 8 36.060 11.15 11.15 8 15 0.222
AST 17.04 15.00 4 140 13.53 13.00 6 29 0.066
ALT 14.61 12.00 3 64 11.95 10.00 2 33 0.055
VES 29.84 25.00 2 84 42.73 39.00 8 101 0.037
PCR 59.65 .30  3.660 1.05 .33  6 0.573
GB 6.39 6.09 2 14 7.98 7.29 3 23 0.038
N 3.71 3.42 1 9 5.05 4.50 2 15 0.018
L 1.72 1.47  4 1.66 1.47  4 0.804
M .47 .45  1 .45 .45  1 0.713
E 98.51 .14  9.504 .23 .18  1 0.089
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Tab.2 Comparisons Simkania positive / negative 
According to Table 2 comparing the two populations , transplanted and dialysis , in relation to the 
positive test laboratory for finding Simkania showed that the largest number of patients testing 
positive were hemodialysis (the figure was considered statistically significant p < 0.007 ) . Also 
checking this figure in relation to sex showed that test positive predominantly women (even this 
figure was considered statistically significant p < 0.005 ) . To conclude evaluating tests positive for 
simkania and comparing it to the presence or absence of symptoms at the time of      collection was 
observed a greater number of patients to symptomatic (this figure , however, has not considered 
statistically significant p 0.566 ) . 
 
Simkania Chi_square, 
p-valueNegativo Positivo
Tx_dialisi
Trapianto
100 10
0.007
53.2% 28.6%
Dialisi
88 25
46.8% 71.4%
SESSO
F
59 20
0.005
32.2% 57.1%
M
124 15
67.8% 42.9%
Sintomi
Nessun 
sintomo
140 25
0.566
81.4% 73.5%
Sintomi 
respiratori
24 7
14.0% 20.6%
Gastro 
intestinali
8 2
4.7% 5.9%
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Tab.3 Comparisons between transplant recipients and subjects on dialysis 
Nonparametric test because the distributions are not normal . 
Age : medians differ statistically significantly ( 53.00 vs. 71.50 ) 
Creatinine : medians differ statistically significantly (1.50 vs. 8:10 ) 
Hb : medians differ statistically significantly ( 12:40 vs. 10:10 ) 
AST : medians differ statistically significantly ( 16:00 vs. 12:00 ) 
ESR : the medians differ statistically significantly (17.00 vs. 41.50 ) 
PCR : the medians differ statistically significantly ( 0:16 vs. 0.68 ) 
L : the medians differ statistically significantly ( 1.67 vs. 1:21 ) 
E: the medians differ statistically significantly ( 0:11 vs. 0:17 ) 
Comparing the total sample used for the study , patients on dialysis and transplants and analyzing 
certain parameters both laboratory data and medical history has shown that the average age was 
higher among patients on dialysis (this figure reached statistical significance p < 0.001 ) , the value 
of creatinine was higher among hemodialysis ( in relation to the difference in expected condition ) , 
the hemoglobin was higher among transplant patients ( statistically significant p < 0.001 ) ; 
transaminases (GOT ) higher in transplanted ( statistical significance p < 0.001 ) ; both the ESR that 
PCR were higher in the patient on hemodialysis ( p <0.001 ) ; the proportion of lymphocytes and 
Totale 
soggetti
Tx_dialisi
Kruskal-
Wallis, p-
value
Trapianto Dialisi
Mean Median Minimum Maximum Mean Median Minimum Maximum
Kt/v     64.43 66.05 23 80 \
età 52.89 53.00 28 77 68.48 71.50 19 90 <0.001
anni trapianto 7.03 5.00 1 30     \
Creatiniemia 1.75 1.50 1 9 8.29 8.10 3 15 <0.001
Proteinuria 38.47 0.00 0 412     \
Hb 12.50 12.40 8 16 677.85 10.10 8 36.060 <0.001
AST 16.62 16.00 6 53 16.44 12.00 4 140 <0.001
ALT 14.56 12.00 4 53 13.71 11.00 2 64 0.222
VES 21.16 17.00 2 63 42.15 41.50 2 101 <0.001
PCR 14.17 .16  960 108.21 .68  3.660 <0.001
GB 6.54 6.25 2 13 6.75 6.23 2 23 0.944
N 3.87 3.69 1 9 3.90 3.36 1 15 0.455
L 1.81 1.67  4 1.55 1.21  4 0.016
M .48 .47  1 .44 .45  1 0.204
E 139.94 .11  9.504 .26 .17  1 <0.001
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eosinophils higher in transplanted ( p < 0.016 and p < 0.001 ) . The non-parametric test was 
conducted according to the method of Kruskal-Wallis . 
Table 4 Comparisons Transplant / Dialysis 
Sex: the percentages of males differ statistically significantly between transplant and dialysis . 
Males tend to be more rather than transplanted dialysis . 
From data collected the sample showed a greater number of patients transplanted male ( p < 0.001), 
and most of the patient did not show any signs of disease especially kidney transplants ( p < 0.011 ) 
and in the remaining part of the cases respiratory symptoms ( prevailing in the dialysate 19.5 % vs 
9.7 % ) , and gastrointestinal ( 7.1 % vs 2.2 % ) . This study was performed according to the method 
Chi square . 
 
Tx_dialisi Chi_square, 
p-valueTrapianto Dialisi
SESSO
F
29 50
0.011
27.6% 44.2%
M
76 63
72.4% 55.8%
Sintomi
Nessun 
sintomo
82 83
0.028
88.2% 73.5%
Sintomi 
respiratori
9 22
9.7% 19.5%
Gastro 
intestinali
2 8
2.2% 7.1%
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Tab . 5 Comparisons selecting only the transplanted 
GB : medians differ statistically significantly ( 6:04 vs. 7:29 ) 
Using to compare the renal transplant patients in relation to positive or not the test for simkania has 
shown that there is a positive correlation between simkania and white blood cell count , reaching 
statistical significance ( p 0.043 ) . 
SOLO 
TRAPIANTATI
Simkania
Kruskal-
Wallis, p-
value
Negativo Positivo
Mean Median Minimum Maximum Mean Median Minimum Maximum
Kt/v         \
età 52.89 53.00 28 77     \
anni trapianto 6.67 4.00 1 30 10.56 12.00 1 22 0.118
Creatiniemia 1.67 1.50 1 4 2.52 1.40 1 9 0.945
Proteinuria 37.59 0.00 0 412 48.00 0.00 0 300 0.885
Hb 12.49 12.40 8 16 12.60 12.40 11 15 0.994
AST 16.87 16.00 6 53 14.25 14.50 9 18 0.278
ALT 14.91 12.50 4 53 11.25 10.00 6 26 0.1
VES 19.95 15.00 2 63 30.40 34.00 8 51 0.172
PCR 15.41 .17  960 .14 .09   0.451
GB 6.43 6.04 2 13 7.54 7.29 6 11 0.043
N 3.79 3.54 1 9 4.75 4.73 3 7 0.095
L 1.80 1.68  4 1.87 1.47 1 4 0.825
M .48 .47  1 .48 .49  1 0.889
E 152.81 .10  9.504 .17 .18   0.394
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Tab . 6 Comparisons selecting only the dialysis 
Comparing patients on hemodialysis in relation to test positive for simkania did not show any 
statistically significant difference . 
The statistical analysis can not be carried out on the IgA IgG S. Negevensis as too reduced the 
sample size . 
SOLO 
DIALIZZATI
Simkania
Kruskal-
Wallis, p-
value
Negativo Positivo
Mean Median Minimum Maximum Mean Median Minimum Maximum
Kt/v 63.80 66.05 23 80 66.83 66.15 59 74 0.448
età 68.48 71.50 19 90     \
anni trapianto         \
Creatiniemia 8.58 8.80 3 15 7.26 7.70 4 11 0.137
Proteinuria         \
Hb 868.62 10.15 8 36.060 10.18 9.85 8 13 0.731
AST 17.37 12.00 4 140 13.00 11.00 6 29 0.318
ALT 14.05 12.00 3 64 12.45 9.00 2 33 0.458
VES 40.28 37.50 2 84 48.90 47.00 25 101 0.311
PCR 134.87 .67  3.660 1.60 .78  6 0.79
GB 6.31 6.18 2 14 8.28 6.94 3 23 0.284
N 3.57 3.30 1 9 5.25 4.26 2 15 0.068
L 1.56 1.17  4 1.51 1.50  3 0.772
M .44 .45  1 .43 .43  1 0.693
E .25 .16  1 .28 .19  1 0.429
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Discussion and Conclusions 
Simkania negevensis resists destruction by free-living amoebae and that may use the amoebae as an 
environmental reservoir (). Its role as an emerging human respiratory pathogen is suspected (). 
Epidemiological studies using PCR, cell culture, and serology have documented not only the 
worldwide presence of this microorganism but also its association with bronchiolitis in infants and 
with lower respiratory tract infections in adults. More recently, S. negevensis DNA has also been 
amplified from human arterial biopsy specimens. 
In our study S. negevensis was tested and found positive in the samples of water taken from the 
circuits for hemodialysis , which is carried out from power the preparation of water for dialysis , 
before and after disinfection treatments , resulting always positive. Our study identifies a population 
that is unexpected positive the SN , the hemodialysis patient. This is to be interpreted in the context 
of the life of the bacterium . Like other Chlamydia-related organisms, S. negevensis may infect 
free-living amoebae such as Acanthamoeba which are widespread in water, including hospital water 
supplies (La Scola et al., 2002).  It spreads in the waters of the network circuits for dialysis, even 
after the treatments to which are subjected the waters . 
Hospitalized patients exposed to aerosolized particles, such as those undergoing mechanical 
ventilation, may thus be colonized or infected by these intracellular bacteria, whose pathogenic role 
in this setting has been poorly investigated. 
However, it is worth noting that in vitro studies of the pathogenesis of S. negevensis have 
demonstrated its ability to infect human macrophages and to induce a host cell inflammatory 
response, supporting its potential ability to cause human infections and the need for further clinical 
investigations (Kahane et al., 2008). 
Free-living amoebae represent a widespread evolutionary niche that may favour the selection of 
virulence traits in intra-amoebal bacteria, enabling them to survive in other phagocytic cells, 
including alveolar macrophages, which are one of a major line of immune defence against invading 
pathogens. The examples of emerging pathogens provided probably represent only the tip of the 
iceberg, and there is still a largely underestimated biodiversity of amoebae-resisting bacteria, which 
may have acquired their ability to cause diseases in humans by the development of virulence traits 
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during their intra-amoebal life. This huge and so far unexplored biodiversity not only includes 
members of the clade presented , i.e. Legionella spp., Chlamydiae, Bradyrhizobiaceae and 
mycobacteria, but also many other bacterial clades and giant viruses (Greub & Raoult, 2004). 
From a recent study ( Donati et al 2013) S. negevensis presents , despite the lack of reference 
literature , a prevalence comparable to that of the general population or in patients on dialysis ( 28.9 
% ) that transplanted ( 15.5 % ) . The prevalence of IgA is elevated in dialysis patients , while being 
comparable to that of the general population (in transplant patients). In our work, it was not possible 
to collect data on the IgA IgG vs SN because the sample was small in numbers . 
S. negevensis has a specific behavior towards patients transplanted , recovering levels of 
seroprevalence overlapping with the general population ; in contrast to what happens for the C. 
pneumoniae with which it shares several characteristics . 
This could be explained by the versatility already highlighted in vitro, of the s . negevensis , 
inducing different types of infection ( active , persistent , cryptic ) , the whose characteristics in 
vivo, however, are yet to be determined for both the healthy population and for the 
immunodepressed .  
Solid organ transplantation is often the only therapeutic option for end-stage organ failure, but 
lifelong immunosuppression is necessary to prevent the rejection of allogeneic transplants. High 
frequencies of alloreactive T cells contribute to the vigour of the allogeneic response that mediates 
rejection. These alloreactive T cells recognize either allogeneic MHC molecules (a process termed 
direct allorecognition) or peptides from donor MHC molecules or minor histocompatibility antigens 
presented on recipient antigen-presenting cells (APCs) (a process termed indirect allorecognition). 
Observations from experimental models indicate that events associated with clinical transplantation, 
such as ischaemia–reperfusion injury and infections, can enhance alloreactivity and promote 
rejection episodes through the release of damage-associated molecular patterns (DAMPs) and 
pathogen-associated molecular patterns (PAMPs), as well as through alterations in the alloreactive T 
cell repertoire. 
Despite the observed correlation between increased frequencies of infections and acute rejection, 
especially in the early post-transplant period, definitive clinical proof that infections stimulate 
alloreactivity is lacking. It was discussed the difficulty in making this causal link: 
immunosuppression used to prevent or treat transplant rejection episodes increases the susceptibility 
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to developing infections but also reduces some of the pro-inflammatory responses normally elicited 
by the infections. Furthermore, some infections trigger the release of endogenous corticosteroids 
that can compromise the pro- inflammatory response to infection. The prophylactic use of 
antibiotics, antifungal drugs and antiviral drugs can also reduce the impact of infections on 
alloreactivity. Finally, tapering of immunosuppression to treat some types of viral infection may 
increase the likelihood of rejection, which then makes a definitive demonstration of the direct 
participation of infections in transplant rejection even more challenging. Infections that occur 
before transplantation include those implicated in the cause of organ failure, such as hepatitis B 
virus (HBV) or HCV infections in the case of liver damage, and those associated with end-stage 
dis- ease, such as bacterial and fungal infections in patients with cystic fibrosis and in patients with 
end-stage renal failure on haemodialysis or peritoneal dialysis. Infections in the post-transplant 
period are shaped by the type of immunosuppression regimen used, the presence of infections in the 
donor organ or recipient, and the use of prophylactic antimicrobial agents. 
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Figure 1 | Possible effects of infections before, at and after transplantation.  
5QOG6|EGNNUURGEKHKEHQTOKETQDKCNRGRVKFGURTGUGPVGFD[UGNH/*%OQNGEWNGUECP
ETQUUTGCEVYKVJCNNQIGPGKE/*%OQNGEWNGUCPFDCEVGTKCNUWRGTCPVKIGPUECPFKTGEVN[
CEVKXCVGNCTIGRQRWNCVKQPUQH6|EGNNU6JGTGHQTGKPHGEVKQPUGZRGTKGPEGFDGHQTG
VTCPURNCPVCVKQPECPIKXGTKUGVQJGVGTQNQIQWUOGOQT[CNNQTGCEVKXG6|EGNNUVJCVOC[DG
OQTGTGUKUVCPVVQKOOWPQUWRRTGUUKQPVJCPPCKXG6|EGNNU15,18. The engagement of  
RCVVGTPTGEQIPKVKQPTGEGRVQTU
244UQPCPVKIGPRTGUGPVKPIEGNNU
#2%U6|EGNNUCPFQT
parenchymal cells at the time of or after transplantation can induce various signals and 
cytokines. This can result in enhanced priming, survival and expansion of alloreactive 
6|EGNNUCUYGNNCUFKEVCVKPIVJGRJGPQV[RGQHFKHHGTGPVKCVKPICNNQTGCEVKXG6|EGNNU+PHGEVKQPU
occurring late after transplantation may elicit pro-inflammatory signals that activate 
VQNGTCPV6|EGNNUD[GPCDNKPIVJGKTGUECRGHTQOKOOWPQUWRRTGUUKQPCPFQTRGTKRJGTCN
mechanisms of tolerance, thereby precipitating rejection. T
Reg
 cell, regulatory T cell.
Donor-specific transfusion
(DST). A treatment for inducing 
transplant tolerance that 
involves the infusion into a 
transplant recipient of spleen 
cells from a donor who also 
provides the organ or tissue.
MHC tetramers 
Fluorescently labelled 
tetravalent complexes of MHC 
class I or class II molecules 
complexed with antigenic 
peptides. They can be used to 
identify antigen-specific T cells 
by flow cytometry.
Severe combined 
immunodeficiency mice 
(SCID mice). Mice with a defect 
in DNA recombination that 
results in an absence of B and 
T cell development. Such mice 
are incompetent at rejecting 
tissue grafts from allogeneic 
and xenogeneic sources.
Superantigen 
A microbial protein that 
activates all T cells expressing 
a particular set of T cell 
receptor (TCR) Vβ chains by 
crosslinking the TCR to a 
particular MHC molecule 
regardless of the peptide 
presented.
donor-specific memory IFNγ-producing lymphocytes in 
renal transplant patients correlated with the risk of post-
transplantation rejection episodes. These observations 
were confirmed in mice16 and more recently in non-
human primates17, in which memory T cells were shown 
to confer resistance to long-term graft acceptance.
The initial experimental demonstration of the impor-
tance of heterologous immunity in transplant rejection 
involved sequential viral infections that generated a 
population of alloreactive memory CD8+ T cells in mice. 
These animals then became resistant to the induction 
of transplant tolerance by co-stimulation blockade and 
donor-specific transfusion (DST) or by bone marrow chi-
merism protocols18. Data demonstrating the participa-
tion of virus-specific T cells in an alloresponse came 
from studies in which mouse memory CD8+ T cells spe-
cific for lymphocytic choriomeningitis virus (LCMV) 
were generated in vivo through LCMV infection19. 
These LCMV-specific T cells were isolated using LCMV 
peptide–self MHC tetramers and were shown to be 
cross-reactive with alloantigens and to induce the acute 
rejection of skin allografts when transferred into severe 
combined immunodeficiency mice (SCID mice).
Based on the structural understanding of direct 
alloreactivity, there is no reason to believe that only 
viruses can generate heterologous immunity. Indeed, 
the infection of mice with the parasite Leishmania 
major was shown to generate memory T cells that are 
cross-reactive with allogeneic MHC molecules and that 
prevent the induction of transplant tolerance to subse-
quent skin grafts20. In addition, some bacterial species 
(such as Staphylococcus and Streptococcus spp.) produce 
toxins with superantigen properties, which allow them to 
activate up to 20% of the T cell repertoire in mice, and 
so these bacteria may also contribute to the generation 
of alloreactive memory T cells21. The ability of infections 
that occur before transplantation to sensitize alloreac-
tive T cells may be particularly important in light of the 
potentially rich history of infections in patients waiting 
for a transplant. Indeed, cross-reactivity between virus-
specific T cells and allogeneic HLA molecules has been 
demonstrated with human T cells14, and a remarkable 
80% of T cell lines and 45% of T cell clones specific 
for EBV, CMV, varicella zoster virus or influenza virus 
cross-react with allogeneic HLA class I or II molecules22.
Nonetheless, despite widespread acceptance that 
hetero logous immunity is a demonstrable barrier to 
successful allograft acceptance in mice, some degree 
of caution is necessary in extrapolating from studies of 
T cell cross-reactivity to pathogenicity, and in assuming 
that hetero logous immunity contributes significantly to 
the T cell pool that mediates organ allograft rejection 
in humans. Indeed, it was observed recently that the 
adoptive transfer of cytotoxic T lymphocytes (CTLs) 
specific for EBV, CMV and/or adenovirus did not result 
in greater graft-versus-host disease in human recipients of 
HLA-mismatched CTLs (with demonstrated broad allo-
reactivity) than in patients who received HLA-matched 
CTLs23. One possible explanation for this observation is 
that memory T cells remain dependent on TCR signalling 
and are therefore susceptible to calci neurin inhibitors, 
which are essential components of clinical transplanta-
tion immunosuppression regimens24. Thus, the impact 
of heterologous immunity and of memory T cells in 
general may be diminished in clinical transplantation. 
In June 2011, belatacept — which is a modified 
CTLA4 (cytotoxic T lymphocyte antigen 4)–immuno-
globulin fusion protein that provides co-stimulatory 
blockade — was approved as an alternative to calci-
neurin inhibitors for the prophylactic treatment of rejec-
tion in adult kidney transplant recipients25. The relative 
resistance of memory T cells to co-stimulation block-
ade raises the possibility that belatacept-based regimens 
may not adequately control memory T cells, and thus 
the role of these cells in clinical rejection may become 
more apparent.
Infections in the post-transplant period. Pathogenic 
bacterial, fungal and viral infections are prevalent in the 
peri- and post-transplant periods as a result of surgi-
cal insult and immunosuppression. Studies evaluating 
defined categories of bacterial infections in transplant 
recipients have been able to link the incidence of bacterial 
infections with transplant rejection (reviewed in REF. 2. 
In patients who have received lung transplants, infections 
with Chlamydia pneumoniae26 or Simkania negeven-
sis27, and colonization of the allograft by Pseudomonas 
aeruginosa28 or Aspergillus spp.29, have been associated 
with the development of acute rejection or bronchiolitis 
obliterans syndrome. Furthermore, urinary tract infections 
(especially those occurring late after renal transplanta-
tion when prophylactic anti biotics have been discontin-
ued) have been associated with chronic rejection and 
renal graft loss30. When infections occur locally in the 
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Pathogenic bacterial, fungal and viral infections are prevalent in the peri- and post-transplant 
periods as a result of surgical insult and immunosuppression. Studies evaluating defined categories 
of bacterial infections in transplant recipients have been able to link the incidence of bacterial 
infections with transplant rejection. In patients who have received lung transplants, infections with 
Chlamydia pneumoniae or Simkania negevensis, and colonization of the allograft by Pseudomonas 
aeruginosa or Aspergillus spp., have been associated with the development of acute rejection or 
bronchiolitis obliterans syndrome. Furthermore, urinary tract infections (especially those occurring 
late after renal transplantation when prophylactic antibiotics have been discontinued) have been 
associated with chronic rejection and renal graft loss. When infections occur locally in the 
transplanted organ, graft injury can result from immune responses directed at the pathogen, from 
the reactivation of alloreactivity and/or from the activation of T cells that recognize cryptic 
autoantigens exposed following cell damage. Despite these reports, unambiguous clinical evidence 
for a causal relationship between infection and transplant rejection is currently lacking. 
 38
 fig 5 potential causes of graft damage during microbial infections. graft destruction during an 
infection can occur through multiple mechanisms a. microorganisms with a tropism for the graft 
organ can have direct cytopathic effects that cause the release of Damage-associated molecular 
patterns (DAMPs) as well as microbial or donor antigens (alloantigens) and possibly autoantigens. 
b recipient antigen-presenting cells (APCs) or endothelial cells in the graft take up and cross-
 39
Nature Reviews | Immunology
CD28TCR
MHC
Microbial peptide
/KETQDKCNURGEKȮE6EGNN
Recipient APC Recipient APC
Alloantigen
&QPQTITCȎEGNN
Recipient or 
donor APC
Alloreactive T cell
Alloreactive T cell
Autoreactive 
T cell
CD80 or CD86
Allogeneic
peptide
2TQKPȯCOOCVQT[
E[VQMKPGU
2TQKPȯCOOCVQT[
E[VQMKPGU
#P[RGRVKFG
Source of 
autoantigens 
and DAMPs
Autoantigen
Self peptide
Source of 
alloantigens 
and DAMPs
Direct
activation
Indirect
activation
5QWTEGQHOKETQDKCN
antigens and DAMPs
)TCȎEGNN
death
b c
a
e
d
Micro-
QTICPKUO
Microbial 
peptide
Figure 3 | Potential causes of graft damage during microbial infections. Graft destruction during an infection can 
occur through multiple mechanisms. a | Microorganisms with a tropism for the graft organ can have direct cytopathic 
effects that cause the release of damage-associated molecular patterns (DAMPs) as well as microbial or donor antigens 
(alloantigens) and possibly autoantigens. b^ 4GEKRKGPVCPVKIGPRTGUGPVKPIEGNNU
#2%UQTGPFQVJGNKCNEGNNU
PQVUJQYPKP
VJGITCHVVCMGWRCPFETQUURTGUGPVGZQIGPQWUOKETQDKCNCPVKIGPUVQTGEKRKGPV6|EGNNU#EVKXCVGF#2%UCPFQT6|EGNNU
secrete cytokines that are damaging to the graft or t at injure endothelial cells, thereby reducing vascular supply to the 
ITCHV1HPQVGYJGP*.#CNNGNGUCTGUJCTGFDGVYGGPVJGTGEKRKGPVCPFFQPQTTGEKRKGPVTGUVTKEVGFCPVKOKETQDKCN6|EGNNUECP
direc ly engage infected donor cells (not shown). c^ +PHGEVKQPUECPKPFWEGVJGOCVWTCVKQPQHTGEKRKGPV#2%UQTCEVKXCVG
endothelial cells (not shown) that have taken up donor antigens (blue triangles). This results in the indirect activation of 
CNNQTGCEVKXG6|EGNNUCPFKPITCHVKPLWT[OGFKCVGFD[RTQKPHNCOOCVQT[E[VQMKPGUCPFVQZKEUQNWDNGHCEVQTUVJCVKPLWTGDNQQF
vessels. d^ 5KOKNCTN[KPHGEVKQPUECPCWIOGPVVJGFKTGEVCEVKXCVKQPQHCNNQTGCEVKXG6|EGNNUD[ enhancing the maturation of 
FQPQT#2%U
PQVUJQYPQTITCHVRCTGPEJ[OCNEGNNUTGUWNVKPIKPITCHVFCOCIGe ^ %GNNWNCTITCHVFCOCIGOC[TGNGCUG
ET[RVKECPVKIGPU
CWVQCPVKIGPUCPF&#/2UVJCVVJGPCEVKXCVGCWVQTGCEVKXG6|EGNNU#HVGTTGGPEQWPVGTKPIVJGUGCPVKIGPU
QPETQUURTGUGPVKPITGEKRKGPV#2%UQTGPFQVJGNKCNEGNNUVJGUGCWVQTGCEVKXG6|EGNNUOC[EQPVTKDWVGVQITCHVFCOCIGKPC
RJGPQOGPQPCPCNQIQWUVQGRKVQRGURTGCFKPI6%46|EGNNTGEGRVQT
graft acceptance36, as has the re-activation of latent 
MCMV infection37. Furthermore, the impact of infec-
tion on graft survival in mice was greater with some 
types of viral infection (such as those mediated by 
LCMV and Pichinde virus) than with other viral infec-
tions, and was also increased when infection occurred 
at or shortly after transplantation38,39. Williams et al.39 
reported that the ability of LCMV infections at the time 
of transplantation to trigger rejection was not due to the 
direct participation of LCMV-specific T cells but rather 
to the stimulation of innate immunity. Specifically, such 
infections enhanced the maturation of dendritic cells 
(DCs), leading to the activation of alloreactive T cells in 
a CD28- and CD40-independent manner (FIG. 2).
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present exogenous microbial antigens to recipient T cells. Activated APCs and or T cells secrete 
cytokines that are damaging to the graft or that injure endothelial cells, thereby reducing vascular 
supply to the graft. c infections can induce the maturation of recipient APCs or activate endothelial 
cells that have taken up donor antigens (blue triangles). This results in the indirect activation of 
alloreactive T cells and graft injury mediated by pro inflammatory cytokines and toxic soluble 
factors that injure blood vessels. d. infections can augment the direct activation of alloreactive T 
cells by enhancing the maturation of donor APCs or graft parenchymal cells, resulting in graft 
damage.e cellular graft damage may release cryptic antigen (autoantigen) and DAMPs that then 
activate auto reactive T cells  
The complex effects of infections and tissue damage on the outcome of transplantation are starting 
to be appre- ciated. Not only do such events induce the generation of memory alloreactive T and 
possibly B cells, but they also give rise to PAMPs and DAMPs, which can promote innate immune 
responses. The tools to analyse the com- plex feedback circuits between immune responses and the 
host microbiota (BOX 3) or infections are just being developed, with some pathways known and 
some postulated to have an impact on alloreactivity. It is likely that further study of how these 
circuits impinge on allo- responses will continue to change our understanding of organ rejection and 
tolerance, and will provide insights into how the effects of infection on alloreactivity can be 
controlled without compromising protective immunity(62). 
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